Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Pharmacology and Toxicology
1000-3002
2016 Issue 1
A review of monoclonal antibody therapy for cancer and prospects
SHEN Bei-fen;Department of Molecular Immunology;Institute of Basic Medical Sciences;Academy of Military Medical Sciences;
..............page:1-6
Strategy of antibody-drug conjugates in preclinical safety evaluation
HONG Min;ZHAO Xiao-ping;MA Jing;National Center for New Drug Safety Evaluation and Research in Shanghai;Shanghai Innostar Biotechnology Co.Ltd.;
..............page:7-12
Key principles of nonclinical safety evaluation for pediatric drugs and characteristics of traditional Chinese materia medica evaluation
SUN Zu-yue;ZHOU Li;HAN Ling;Shanghai Institute of Planned Parenthood Research;National Evaluation Center for Toxicology of Fertility Regulating Drugs;Center for Drug Evaluation;China Food and Drug Administration;
..............page:13-20
Determination of parameters of developmental toxicity study on pediatric drugs and focus of attention for safety evaluation of traditional Chinese medicine
ZHOU Li;SUN Zu-yue;Shanghai Institute of Planned Parenthood Research;National Evaluation Center for Toxicology of Fertility Regulating Drugs;
..............page:21-28
Asiaticoside attenuates bleomycin-induced interstitial pulmonary fibrosis
YE Wen-jing;ZHU Xiao-chun;WANG Xiao-bing;WANG Liang-xing;XIE Xu-ying;Department of Rheumology;the First Affiliated Hospital of Wenzhou Medical University;Department of Respiratory Medicina;the First Affiliated Hospital of Wenzhou Medical University;Pharmaceutical Department;the First Affiliated Hospital of Wenzhou Medical University;
..............page:29-37
Effects of quinolinic acid on autophagy and protein expressions of related signaling pathway in PC12 cells
LI Yong-jin;ZHANG Yi;YANG Kai-yong;AN Ke;ZHANG Zhuang;KAN Mei-jia;CHEN Yue-fang;PAN Hai-yuan;HUANG Xiao-jia;School of Medicine;Jiangsu University;Department of Pharmacy;The 82nd Hospital of PLA;
..............page:38-43
Xiaoaiping injection combined with gefitinib inhibits resistant non-small cell lung cancer xenografts H460 and H1975
HAN Shu-yan;ZHENG Wen-xian;HE Xi-ran;ZHAO Can;JIANG Shan-tong;PANG Li-Na;LI Xiao-hong;LI Ping-ping;Key Laboratory of Carcinogenesis and Translational Research;Department of Integration of Chinese and Western Medicine;Peking University Cancer Hospital & Institute;
..............page:44-52
Therapeutic effect of arctigenin on carbon tetrachloride-induced liver fibrosis in rats
ZHANG Xiao-xun;WANG Jun;ZHAO Yu;ZHANG Jing-yao;LI Ao;College of Pharmacy and Bioengineering;Chongqing University of Technology;
..............page:53-60
Anticancer effects of heparinized mesoporous silicon nanoparticles drug carrier system on H22 tumorbearing mice and its liver and kidney toxicity
LI Rui-fang;WU Qiang;XU Xin-li;LIU He-yang;FU Jun-min;FENG Xiang-guan;Laboratory of Pharmacology and Molecular Biology;Medical College;Henan University of Science and Technology;College of Pharmacy;Institute of Chinese Materia Medica;Henan University;
..............page:61-67
Effect of overexpression of vascular cell adhesion molecule-1 on migration of murine mesenchymal stem cells
CHENG Yan;ZHU Heng;LIU Yuan-lin;WANG Yan-guo;ZHAO Yue;CHEN Xiu-hui;YANG Zhen-lin;ZHANG Yi;Department of Thyroid and Breast Surgery;Affiliated Hospital of Binzhou Medical College;Institute of Basic Medical Sciences;Academy of Military Medical Sciences;Department of Pathophysiology;Baotou Medical College;Department of Obstetrics and Gynecology;Air Force General Hospital;
..............page:68-73
A physiologically based toxicokinetics and toxicodynamics model in rats following both oral and subcutaneous exposure to chlorpyrifos
CAO Zheng-ying;YAO Xin-ya;ZHAO Min-xian;WANG Can-nan;Ministry of Education Key Laboratory of Environmental Medical Engineering;Department of Nutrition and Food Hygiene;School of Public Health;Southeast University;
..............page:74-81
Roles of protein tyrosine phosphatase SHP2 in lung cancer
HE Ling-juan;CHENG Hong-qiang;KE Yue-hai;WANG Lin-run;Zhejiang University 1.The First Affiliated Hospital;College of Medicine;Department of Pathology and Pathophysiology;School of Basic Medical Sciences;
..............page:82-86